Relative to its peers, NNVC does not have very much institutional sponsorship. The 5.06% of shares outstanding held by institutional investors is among the least of any stock in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
RENAISSANCE TECHNOLOGIES LLC Bought 40.9 Thousand shares of NanoViricides Inc
THE VANGUARD GROUP, INC. Bought 12.2 Thousand shares of NanoViricides Inc
NORTHERN TRUST INVESTMENTS, INC. Bought 11.2 Thousand shares of NanoViricides Inc